Pathogenesis of neuroimmunologic diseases. Experimental models.
Animal models of autoimmune diseases have greatly improved our current understanding of the pathogenesis of human autoimmunity and have provided the potential for therapies based on manipulation of the immune system. In our laboratory, we have investigated the immunopathogenesis of autoimmune diseases of the nervous system and muscle. We have developed immune-based approaches for the suppression of experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS), and experimental autoimmune neuritis (EAN), a model for the Guillain-Barré syndrome (GBS). These approaches included induction of peripheral tolerance, immunotoxin targeting of activated T cells, and cytokine manipulations. In addition, we identified the antigen and characterized immunopathologically an autoimmune inflammatory disease of skeletal muscle, experimental autoimmune myositis (EAM), a model for the human inflammatory muscle disease polymyositis.
Constantinescu
C S
CS
Department of Neurology, University of Pennsylvania Medical Center, Philadelphia 19104, USA.
Hilliard
B
B
Fujioka
T
T
Bhopale
M K
MK
Calida
D
D
Rostami
A M
AM
D000818:Animals; D004195:Disease Models, Animal; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D009103:Multiple Sclerosis / Q000276:immunology* / Q000628:therapy; D009444:Neuritis, Autoimmune, Experimental / Q000276:immunology* / Q000628:therapy; D017285:Polymyositis / Q000276:immunology; D011129:Polyradiculoneuropathy / Q000276:immunology* / Q000628:therapy